URL | https://www.fiercepharma.com/manufacturing/35m-inv |
Source | Fierce Pharma |
Date Published | 08/19/2021 |
Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
Company/Division name | Curia |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Year reshoring announced: | 2021 |
Domestically, the work will be done: | In-house |
Capital investment ($): | 35 |
City reshored to: | Rensselaer |
State(s) reshored to: | NY |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | high-potency API |